What did Morningstar subscribers buy and sell during June?

Morning Star AU07-14

This monthly review of our subscribers’ top trades from Sharesight marks the end to the financial year. In the past six months, we have seen large swings in the most actively traded companies and ETFs...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2651122650?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-14 00:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2651122650","market":"us","top_or_hot":-1,"title":"What did Morningstar subscribers buy and sell during June?","media":"Morning Star AU","content":"<div>\n<p>This monthly review of our subscribers’ top trades from Sharesight marks the end to the financial year. In the past six months, we have seen large swings in the most actively traded companies and ETFs...</p>\n\n<a href=\"https://www.morningstar.com.au/stocks/what-did-morningstar-subscribers-buy-sell-during-june\">Source Link</a>\n\n</div>\n","source":"morningstar_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What did Morningstar subscribers buy and sell during June?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat did Morningstar subscribers buy and sell during June?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-07-14 00:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.morningstar.com.au/stocks/what-did-morningstar-subscribers-buy-sell-during-june><strong>Morning Star AU</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>This monthly review of our subscribers’ top trades from Sharesight marks the end to the financial year. In the past six months, we have seen large swings in the most actively traded companies and ETFs...</p>\n\n<a href=\"https://www.morningstar.com.au/stocks/what-did-morningstar-subscribers-buy-sell-during-june\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IISV.AU","symbol_name":"INTELL INV SELVAL SHR FD MF","start_time":0,"source_url":"https://www.morningstar.com.au/stocks/what-did-morningstar-subscribers-buy-sell-during-june","article_id":"2651122650","we_media_id":null,"thumbnails":[],"rights":{"source":"morningstar_stock","url":"https://www.morningstar.com.au/stocks/what-did-morningstar-subscribers-buy-sell-during-june","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2651122650","pubTimestamp":1783958400,"columns":[],"sourceInfo":{"source_id":"morningstar_stock","name":"Morning Star"},"weMediaInfo":null,"summary":"This monthly review of our subscribers’ top trades from Sharesight marks the end to the financial year. In the past six months, we have seen large swings in the most actively traded companies and ETFs","collect":0,"end_time":0,"defaultTopTitle":"morningstar.com.au","property":[],"viewcount":null,"language":"en","relate_stocks":{"IISV.AU":"INTELL INV SELVAL SHR FD MF","XAO.AU":"标普/澳交所 普通股指数","QFN.AU":"BetaShares Australian Fincls Sect ETF","LU1878469433.USD":"THREADNEEDLE (LUX) - AMERICAN SMALLER COMPANIES \"A\" (USD) ACC","XJO.AU":"标普/澳交所 200指数","BBOZ.AU":"BETASHARES AUSTRALIAN STRONG BEAR (HEDGE FUND)","QRE.AU":"BetaShares Australian Res Sect ETF","GEAR.AU":"BETASHARES GEARED AUS EQTY F","VGT":"信息技术ETF-Vanguard","LU2065731478.USD":"ALLSPRING (LUX) WORLDWIDE FUND - SMALL CAP INNOVA \"I\" (USD) ACC","XKO.AU":"标普/澳交所 300指数","BEAR.AU":"BETASHARES AUS EQ BEAR HF","DACE.AU":"DIMENSIONAL AUST CORE EQ","GIVE.AU":"PERPETUAL ESG AU SHR EQMF","PME.AU":"PRO MEDICUS LTD","ZYAU.AU":"Etfs S&p/asx 300 High Yield Plus Etf","E200.AU":"SPDR S&P/ASX 200 ESG FUND","MORN":"晨星信息","IOZ.AU":"iShares Core S&P/ASX 200","VAP.AU":"VANGUARD AU PROP SEC IDX ETF","VGS.AU":"VANGUARD MSCI IND INTL ETF","VAS.AU":"VANGUARD AUST SHARES IDX ETF","BK7503":"科技股","XRO.AU":"XERO LTD","STW.AU":"SPDR® S&P/ASX 200 ETF","OZF.AU":"SPDR S&P/ASX 200 FINANCIALS","BK7094":"医疗保健技术","OZR.AU":"SPDR S&P/ASX 200 RESOURCES F","QQH":"HCM Defender 100 Index ETF","IMLC.AU":"INV MUTUAL CONC AUS SHAR ETF","BK4112":"金融交易所和数据","IIGF.AU":"Intelligent Investor Australian Equity Growth Fund (Managed Fund)","SLF.AU":"SPDR S&P/ASX 200 LISTED PROP","BK7016":"应用软件","BK4598":"佩洛西持仓","EIGA.AU":"EINVEST INCOME GENERATOR FD"},"translate_title":"晨星订户在六月份买卖了什么？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"STW.AU":0.6,"XKO.AU":0.9,"IIGF.AU":0.6,"PME.AU":1,"QFN.AU":0.6,"XAO.AU":0.9,"DACE.AU":0.6,"GEAR.AU":0.6,"VAS.AU":1,"OZF.AU":0.6,"VAP.AU":0.6,"QRE.AU":0.6,"E200.AU":0.6,"GIVE.AU":0.6,"BEAR.AU":0.6,"XRO.AU":1,"MORN":1.5,"QQH":0.77,"IISV.AU":0.6,"VGS.AU":1,"XJO.AU":0.9,"IMLC.AU":0.6,"OZR.AU":0.6,"EIGA.AU":0.6,"SLF.AU":0.6,"ZYAU.AU":0.6,"BBOZ.AU":0.6,"IOZ.AU":0.6,"VGT":0.6},"content_text":"This monthly review of our subscribers’ top trades from Sharesight marks the end to the financial year. In the past six months, we have seen large swings in the most actively traded companies and ETFs. The core themes driving market sentiment have evolved around AI narratives, global conflict and resource bottlenecks. Sharesight is a portfolio tracker that is integrated into Morningstar Investor. Their data shows the top 20 trades by Morningstar subscribers in June. Sharesight’s data below ranks total trading activity which is split between sells (orange) and buys (yellow).Trends in June Vanguard Australian Shares ETF (ASX:VAS) claimed the top spot as the most traded security in June, overtaking both CSL (ASX.CSL) and WiseTech (ASX.WTC). The Vanguard MSCI International Shares ETF (ASX:VGS) also surged to second place. WiseTech has remained firmly in the top three, highlighting continued investor interest following a 70% fall in the share price over the past year. Amongst direct equities, Xero (ASX:XRO) re-entered the top 20 after dropping out in April and May, while Pro Medicus (ASX:PME) returned following a one-month hiatus in May. The data continues to indicate a notable shift towards broad-based portfolio products, with 8 of the Top 10 most traded securities in June being ETFs. Let’s dive into the three biggest investment trends from June and test the narratives against our analysts’ views. Xero (ASX.XRO) Fair Value Estimate: $100 (36% discount at 10 July) Rating: ★★★★ Moat: Narrow Xero is a cloud-based accounting software company which provides solutions for small to medium businesses. The business was launched in New Zealand, before expanding its operations to Australia in 2009. Xero now owns approximately 60% of market share in Australia and around 80% in New Zealand across small to medium businesses. Xero has a first mover advantage which has allowed them to entrench themselves as a “must need” software for SMEs. This has created broader network effects which is a key contributor to its narrow moat rating. The company’s addressable market is now largely impenetrable for new competitors which is reflected in Xero’s capture rate of new SMEs and attractive customer acquisition costs. Our analyst Roy van Keulen notes that the Australian and New Zealand businesses are expected to remain highly profitable for Xero over the long run. However, Roy is less optimistic about Xero’s international endeavours particularly in the US. Although there is growth potential overseas, fiercer competition is expected to degrade the attractiveness of Xero’s cost to acquire new customers. The cost of acquisition is a key metric for profitability particularly for software companies. Xero shares have fallen 58% over the past 12 months and now screen as materially undervalued. Roy notes that while the expansion into the US is a relatively unattractive investment opportunity, the market is currently underestimating the value of the ANZ business. Pro Medicus (ASX.PME) Fair Value Estimate: $54 (264% premium at 10 July) Rating: ★ Moat: Narrow Pro Medicus is a provider of software for radiologists to quickly view, enhance and manipulate images from any device and make a diagnosis. Shares have fallen 37% in the last year due to increasing angst that advances in artificial intelligence will affect software firms such as Pro Medicus. Its narrow moat rating is derived from the switching costs associated with its lengthy customer contracts which typically range from five to 10 years. Lengthy contracts allow Pro Medicus to entrench itself at hospitals as the preferred provider. Our analyst Brian Han estimates that Pro Medicus’ addressable market share is around 12% in the US currently. Assuming the market grows at 4% on volume and price increases, this implies that its market share doubles to 24% by fiscal 2035, covering most key target academic hospitals. While Pro Medicus is expected to gain market share in the medium term based on current speed advantages and fast deployment, Brian sees competitors closing the gap over the long term. Advances in artificial intelligence, harnessed by software developers also increase the threat of competition. There are relatively low barriers to entry into the industry and competitors are increasingly better positioned to catch up. Despite the recent correction in the share price, PME is still significantly overvalued based on our $54 price target. The primary valuation concern evolves around the core addressable market which remains limited. However, Brian notes there are avenues for growth outside of radiology which include speciality departments in hospitals. The key question for PME will be whether its product differentiation is durable, with low barriers to entry and larger competitors already utilising server-side rendering and cloud-native architecture. Vanguard Australian Shares ETF (ASX.VAS)Rating: Bronze The Vanguard Australian Shares ETF follows a passive strategy, aiming to replicate the S&P/ASX 300 index. The ASX 300 Index is a market cap weighted index adjusted for free float. This includes approximately 300 of Australia’s largest companies and the index is rebalanced semi-annually. This broad index has attributes which are unique to the Australian market. For example, BHP Group (ASX.BHP) currently makes up around 11% of the index while Commonwealth Bank (ASX.CBA) makes up 10%. The top 10 holdings make up roughly half of the index. In terms of sectors, the Aussie market is also very narrow. This means that the financial services and mining dominate weighting. This index has a tilt toward cyclical sectors which tend to align with the performance of the wider Australian economy. This concentration should be considered, especially when combining multiple ETFs in a portfolio. Overall, our manager research team believe that this ETF is an acceptable choice for core Australian equity exposure, awarding it a Bronze medallist rating. The ETF fees are 0.07% per year which translates into a Medallist Rating Price Score of 2.37. The Price Score ranges from -2.50 (most expensive) to +2.50 (cheapest), with higher scores indicating better cost competitiveness. Get Morningstar’s insights in your inbox","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2651122650","isCrawlerRequest":true}